Search research articles
Contact Us
Filters
Showing results (61-70 of 163) with videos related to
Page
of 17
Sort By:
Cancer Research
|
February 22, 2012
Combinatorial chemotherapeutic efficacy in non-Hodgkin lymphoma can be predicted by a signaling model of CD20 pharmacodynamics
John M Harrold, Robert M Straubinger, Donald E Mager
The Journal of Pharmacology and Experimental Therapeutics
|
November 2, 2012
Systems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacy
Sihem Ait-Oudhia, Robert M Straubinger, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics
|
January 8, 2018
Boolean network modeling in systems pharmacology
Peter Bloomingdale, Van Anh Nguyen, Jin Niu, et al.
The AAPS Journal
|
March 25, 2011
Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data
Leonid Kagan, Pavel Gershkovich, Kishor M Wasan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 22, 2010
Type I interferon receptor is a primary regulator of target-mediated drug disposition of interferon-beta in mice
Anson K Abraham, Leonid Kagan, Sarmishtha Kumar, et al.
Pharmaceutical Research
|
June 25, 2013
Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition
Leonid Kagan, Pavel Gershkovich, Kishor M Wasan, et al.
Cancer Chemotherapy and Pharmacology
|
March 23, 2019
Rituximab dosing in hematological malignancies: an old question, revisited
Peter N Morcos, Axel Boehnke, Nancy Valente, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 26, 2010
Pharmacokinetics and toxicodynamics of pralidoxime effects on paraoxon-induced respiratory toxicity
Pascal Houzé, Donald E Mager, Patricia Risède, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 17, 2004
Exendin-4 pharmacodynamics: insights from the hyperglycemic clamp technique
Donald E Mager, Darrell R Abernethy, Josephine M Egan, et al.
Journal of Pharmaceutical Sciences
|
April 25, 2003
Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in man
Gerhard Levy, Donald E Mager, Wing K Cheung, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 163) with videos related to
Sort By:
Page
of 17
Cancer Research
|
February 22, 2012
Combinatorial chemotherapeutic efficacy in non-Hodgkin lymphoma can be predicted by a signaling model of CD20 pharmacodynamics
John M Harrold, Robert M Straubinger, Donald E Mager
The Journal of Pharmacology and Experimental Therapeutics
|
November 2, 2012
Systems pharmacological analysis of paclitaxel-mediated tumor priming that enhances nanocarrier deposition and efficacy
Sihem Ait-Oudhia, Robert M Straubinger, Donald E Mager
Journal of Pharmacokinetics and Pharmacodynamics
|
January 8, 2018
Boolean network modeling in systems pharmacology
Peter Bloomingdale, Van Anh Nguyen, Jin Niu, et al.
The AAPS Journal
|
March 25, 2011
Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data
Leonid Kagan, Pavel Gershkovich, Kishor M Wasan, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 22, 2010
Type I interferon receptor is a primary regulator of target-mediated drug disposition of interferon-beta in mice
Anson K Abraham, Leonid Kagan, Sarmishtha Kumar, et al.
Pharmaceutical Research
|
June 25, 2013
Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition
Leonid Kagan, Pavel Gershkovich, Kishor M Wasan, et al.
Cancer Chemotherapy and Pharmacology
|
March 23, 2019
Rituximab dosing in hematological malignancies: an old question, revisited
Peter N Morcos, Axel Boehnke, Nancy Valente, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
May 26, 2010
Pharmacokinetics and toxicodynamics of pralidoxime effects on paraoxon-induced respiratory toxicity
Pascal Houzé, Donald E Mager, Patricia Risède, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 17, 2004
Exendin-4 pharmacodynamics: insights from the hyperglycemic clamp technique
Donald E Mager, Darrell R Abernethy, Josephine M Egan, et al.
Journal of Pharmaceutical Sciences
|
April 25, 2003
Comparative pharmacokinetics of coumarin anticoagulants L: Physiologic modeling of S-warfarin in rats and pharmacologic target-mediated warfarin disposition in man
Gerhard Levy, Donald E Mager, Wing K Cheung, et al.
Page
of 17